Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

In vivo exposure of human lymphocytes to technetium-99m in nuclear medicine patients does not induce detectable genetic effects.

Kelsey KT, Donohoe KJ, Memisoglu A, Baxter B, Caggana M, Liber HL. In vivo exposure of human lymphocytes to technetium-99m in nuclear medicine patients does not induce detectable genetic effects. Mutat Res. 1991 Dec; 264(4):213-8.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.